{"name":"Teon Therapeutics, Inc.","slug":"teon-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPME95RFdXUTd3V2ljOU41YVdaNkkzMlhWdFNEMXlnLUxUUnVpMV90dkFaSG9DS0N5eXotN3dPakU3RGRNRFY3S3ZRNUN5LWtHN01UYjg3cUc1UUJzUWVkNmlXMnBCdzhEZlppMUd0dG4xaW9GQXpaNTdmdGZ2YmdpLTdWMGpGNHY5WEpYYVFKcHphZG1GWU5MaE9aTzZYN2ZOS2JhZms0UEpwNlNRa3ZxWW5JbVRxbWs3VmtCNE84VmZMa3RKLU5mV1V2OFdDZmJKWk1JT1JIYnBNWEE0RzZSSXhkUzZNZDdMMlBxcXhIdk9xV25PVEZ3ZGlyckpRTVRMdHE1QXZDYkFYTVFWc3pxM0RR?oc=5","date":"2025-04-23","type":"deal","source":"Business Wire","summary":"Creyon Bio Appoints Industry Leader, Serge Messerlian as CEO, Leveraging Decades of Company Building and Strategic Collaborations - Business Wire","headline":"Creyon Bio Appoints Industry Leader, Serge Messerlian as CEO, Leveraging Decades of Company Building and Strategic Colla","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQdlZ0YlZ2VV9FSGZUbjVWVWp6enJXUy1CS05KWUtKSVN1V2twNVFPaldnY1B4VTFIdlR3aWxwV3B6NkdYWHc1RHQ3ZDRGcllYZGdPQmRFWWxPRWh3ZTZPcHhGS0dEelNPNFRUNnNfbFQtLWZ0WF8tSTBqQmsxTkJEc0tORjNXeHNpOXdQSkdyUk9GRTQ3bXpFY0hsLThBSFRoMkdhSm1n?oc=5","date":"2025-02-13","type":"pipeline","source":"citybiz","summary":"AltPep Corporation Appoints Alan Colowick, M.D., M.P.H. To Its Board - citybiz","headline":"AltPep Corporation Appoints Alan Colowick, M.D., M.P.H. To Its Board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOUGl5WFQ3dHpxazY2T0NTWDdCbWN2bDlxZFVWaFh3Um52bUJGbzRTVnFhSEplYk5WaHFidDZGMngxend4cFBZbncyWWhwekkyWV9sMjdYbENKV1JnbnRPRmtnYTZ2dkFTUGkzZGRRQ3NvTzNRLUlsZzRfUUFKZFg0eWV1MXpLeURQMXVxRFMwaXJYRGY1QXlj?oc=5","date":"2024-10-29","type":"pipeline","source":"Labiotech.eu","summary":"GPCR therapies: Eight promising biotechs hacking the cell signaling pathway - Labiotech.eu","headline":"GPCR therapies: Eight promising biotechs hacking the cell signaling pathway","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNd0xfQ0dxa0VhdGNvZ1pjd21Td2ZuSS0zbjNqMWtDU1dmNU5CLV8xUkFsdVR5TjJFQTBrdVdudjg0WGN4QUJrdmNJYnZ2TEVTVnFFTXFxQU5STWdKc21XbkNMM0JuWXpqUTNFVklKcUpzTk4yV21DS2lPR1Yxd0dERWUtc1ExOTRfcF84MWI0MFNiLS1ZclZKM0FBS3dUbndRWU4wLUhHM2xndFRFcHVKak52cVUxWS1MM0NlUUQ5NkF2UEJKY1ZtMTRZbkkxenFYVGstVUw3TnNvUHlaQkNpMlAxeXZwdl8wdkFvQVBmbEV2ZXk5YlYzSkV6dkJ2bm9rb2lGWmVJcEw2czgyZEJscFB2cUdrdlRXcllUbnZVVVNxSUx0M0x6YlA0Z0ZNZ29VTVpXbE9Tdw?oc=5","date":"2024-01-08","type":"trial","source":"GlobeNewswire","summary":"HDAC Inhibitor Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"HDAC Inhibitor Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOdzR2X1VwNmU3LXl4cUFBal9aZDk3VVBRNml4eDZDN1VBZC1hcm1FRGlXdFRoejE4TVhZQVhpOHpjNGkxc2xvc2RZbUMtUm5Ed3FqT0w1aDBTR1RSa3JoOXRoc2RORUdPeVFUMEZqMzh5R05hU00tVkk5VmRRNHZ3QUxpTGhUTy1NcEhmdnFKeXV2RlJWV3BHYXIyZzRhUzQ?oc=5","date":"2023-03-07","type":"pipeline","source":"BioPharma Dive","summary":"GPCR-targeting drugs: A renewed focus on a ubiquitous group of proteins - BioPharma Dive","headline":"GPCR-targeting drugs: A renewed focus on a ubiquitous group of proteins","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9jZ01zY1dQWFczNzJrRk1wRXdkZG8ySWFyOGFiTzhZQ3k4bXhDalJmbjdHdWxPbkRmNXR4elhFdnE2eDhIVk95X0diLVFpUWh2WWIzYlBOWko5R1dyTmJhYWlKeFdSWkEzdGM1TzhR?oc=5","date":"2022-03-10","type":"pipeline","source":"BioSpace","summary":"BioSpace Movers & Shakers, March 11 - BioSpace","headline":"BioSpace Movers & Shakers, March 11","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9RRV80a2sxYlhialpYdmZmekVqSDBIMklkSGxLNDFpTFZrTVJqZzhfS00zNzBJWWd5amJDeExzVm5PT0xvRWlIWUNhMmpXb1hzS2MzTEY1YUQ5dDZFXzBQRU16NnpwdmplamhlSl9CeDdLVm1jdTFDdlZ0ZG0?oc=5","date":"2022-03-08","type":"pipeline","source":"BioSpace","summary":"Teon Therapeutics Names Serge Messerlian as CEO - BioSpace","headline":"Teon Therapeutics Names Serge Messerlian as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPMV81TERoQjd6U09FYWM5THRiYjNoMlJSZ3hYOXpyZjl2N3ZKSmdGYVdKb05VMXl2Z1pUalkyVDdSUTY4ODRuMVZxT19KeWJuTlZJMHdfeWxvYzZwLXJaaU8wQkRoc2x5UFJVM1VzazUtNmVkdDdNWEdQOHNxczZjM3NoV3QxNms5cXE3T05WdEtPQmpvVW5FWHd5VnJ6X0RKRE1mdGlZNHRjTEticnQtVWUtOA?oc=5","date":"2021-02-23","type":"pipeline","source":"PR Newswire","summary":"Teon Therapeutics Completes $30 Million Series A Financing - PR Newswire","headline":"Teon Therapeutics Completes $30 Million Series A Financing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}